191 related articles for article (PubMed ID: 37397366)
1. Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.
Torres-Sanchez A; Rivera-Robles M; Castillo-Pichardo L; Martínez-Ferrer M; Dorta-Estremera SM; Dharmawardhane S
Front Oncol; 2023; 13():1152458. PubMed ID: 37397366
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.
Medina JI; Cruz-Collazo A; Del Mar Maldonado M; Gascot TM; Borrero-Garcia LD; Cooke M; Kazanietz MG; O'Farril EH; Vlaar CP; Dharmawardhane S
Cancer Res Commun; 2022 Dec; 2(12):1711-1726. PubMed ID: 36861094
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
4. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.
Montalvo-Ortiz BL; Castillo-Pichardo L; Hernández E; Humphries-Bickley T; De la Mota-Peynado A; Cubano LA; Vlaar CP; Dharmawardhane S
J Biol Chem; 2012 Apr; 287(16):13228-38. PubMed ID: 22383527
[TBL] [Abstract][Full Text] [Related]
5. Development of EHop-016: a small molecule inhibitor of Rac.
Dharmawardhane S; Hernandez E; Vlaar C
Enzymes; 2013; 33 Pt A(Pt A):117-46. PubMed ID: 25033803
[TBL] [Abstract][Full Text] [Related]
6. The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model.
Castillo-Pichardo L; Humphries-Bickley T; De La Parra C; Forestier-Roman I; Martinez-Ferrer M; Hernandez E; Vlaar C; Ferrer-Acosta Y; Washington AV; Cubano LA; Rodriguez-Orengo J; Dharmawardhane S
Transl Oncol; 2014 Oct; 7(5):546-55. PubMed ID: 25389450
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer.
Velázquez-Vega LE; Rivera-Robles M; Sánchez-Álvarez AO; Vivas-Mejía PE; Aponte-Reyes M; Cruz-Collazo AM; Grafals-Ruiz N; Dorta-Estremera S; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
Transl Oncol; 2024 Jun; 44():101928. PubMed ID: 38489873
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.
Cruz-Collazo A; Ruiz-Calderon JF; Picon H; Borrero-Garcia LD; Lopez I; Castillo-Pichardo L; Del Mar Maldonado M; Duconge J; Medina JI; Bayro MJ; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2021 Dec; 20(12):2420-2432. PubMed ID: 34607932
[TBL] [Abstract][Full Text] [Related]
9. The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer.
Crespo GV; Ortiz J; O'Farrill EH; Vlaar CP; Inyushin M; Kucheryavykh Y; Kucheryavykh L
Mol Med; 2023 Jun; 29(1):75. PubMed ID: 37316799
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae.
Rivera-Robles MJ; Medina-Velázquez J; Asencio-Torres GM; González-Crespo S; Rymond BC; Rodríguez-Medina J; Dharmawardhane S
Small GTPases; 2020 Nov; 11(6):430-440. PubMed ID: 29969362
[TBL] [Abstract][Full Text] [Related]
11. Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation.
Roney KE; O'Connor BP; Wen H; Holl EK; Guthrie EH; Davis BK; Jones SW; Jha S; Sharek L; Garcia-Mata R; Bear JE; Ting JP
PLoS One; 2011; 6(9):e24795. PubMed ID: 21966369
[TBL] [Abstract][Full Text] [Related]
12. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
13. Targeting Rac and Cdc42 GEFs in Metastatic Cancer.
Maldonado MDM; Medina JI; Velazquez L; Dharmawardhane S
Front Cell Dev Biol; 2020; 8():201. PubMed ID: 32322580
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Rac inhibitor EHop-016 in mice by ultra-performance liquid chromatography tandem mass spectrometry.
Humphries-Bickley T; Castillo-Pichardo L; Corujo-Carro F; Duconge J; Hernandez-O'Farrill E; Vlaar C; Rodriguez-Orengo JF; Cubano L; Dharmawardhane S
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():19-26. PubMed ID: 25594952
[TBL] [Abstract][Full Text] [Related]
15. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
16. Vav regulates activation of Rac but not Cdc42 during FcgammaR-mediated phagocytosis.
Patel JC; Hall A; Caron E
Mol Biol Cell; 2002 Apr; 13(4):1215-26. PubMed ID: 11950933
[TBL] [Abstract][Full Text] [Related]
17. Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.
Borrero-García LD; Del Mar Maldonado M; Medina-Velázquez J; Troche-Torres AL; Velazquez L; Grafals-Ruiz N; Dharmawardhane S
BMC Cancer; 2021 Jun; 21(1):652. PubMed ID: 34074257
[TBL] [Abstract][Full Text] [Related]
18. A role for Cdc42 in macrophage chemotaxis.
Allen WE; Zicha D; Ridley AJ; Jones GE
J Cell Biol; 1998 Jun; 141(5):1147-57. PubMed ID: 9606207
[TBL] [Abstract][Full Text] [Related]
19. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
20. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
